DGI:ZNS-Infektionen/Anmerkung der Redaktion - Revision history

imported>Maximilian.schons@uk-koeln.de: Maximilian.schons@uk-koeln.de verschob die Seite DGI:ZNS Infektionen/Anmerkung der Redaktion nach DGI:ZNS-Infektionen/Anmerkung der Redaktion: Textersetzung - „ZNS Infektionen“ durch „ZNS-Infektionen“

2021-08-03T07:43:28Z

Maximilian.schons@uk-koeln.de verschob die Seite DGI:ZNS Infektionen/Anmerkung der Redaktion nach DGI:ZNS-Infektionen/Anmerkung der Redaktion: Textersetzung - „ZNS Infektionen“ durch „ZNS-Infektionen“

← Older revision		Revision as of 07:43, 3 August 2021
(No difference)

imported>Brinkery: Der Seiteninhalt wurde durch einen anderen Text ersetzt: „== Anmerkung der Redaktion ==
“

2020-12-14T23:25:58Z

Der Seiteninhalt wurde durch einen anderen Text ersetzt: „== <big>Anmerkung der Redaktion</big> == <br />“

Show changes

imported>Brinkery at 20:08, 20 November 2020

2020-11-20T20:08:04Z

← Older revision		Revision as of 20:08, 20 November 2020
Line 161:		Line 161:

	<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif;		<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif;
	mso-fareast-font-family:Arial"><span style="mso-list:Ignore">60.<span style="font:7.0pt "Times New Roman""> </span></span></span>Blassmann U ~~et al~~., Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. ~~<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif">~~Crit Care 2016; 20: 343</span>		mso-fareast-font-family:Arial"><span style="mso-list:Ignore">60.<span style="font:7.0pt "Times New Roman""> </span></span></span>

			<span style="color: rgb(51, 51, 51)">Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 2016; 20: 343</span>

	<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif;		<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif;
Line 173:		Line 175:

	<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif;		<span style="font-size:10.0pt;line-height:115%;font-family:"Arial",sans-serif;
	mso-fareast-font-family:Arial"><span style="mso-list:Ignore">63.<span style="font:7.0pt "Times New Roman""> </span></span></span>Tunkel AR ~~et al~~., 2017 ~~infectious diseases society~~ of ~~america´s clinical practice guidelines~~ for ~~healthcare~~-~~associated ventriculitis~~ and ~~meningitis. <span style="font-size:10~~.~~0pt;line-height:115%;~~		mso-fareast-font-family:Arial"><span style="mso-list:Ignore">63.<span style="font:7.0pt "Times New Roman""> </span></span></span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TB, Garton HJL, Zunt JR. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65
	~~font-family:"Arial",sans-serif">~~Clin Infect Dis 2017; 64:~~34-65</span>~~

	<span style="mso-list:		<span style="mso-list:

imported>Brinkery at 20:01, 20 November 2020

2020-11-20T20:01:42Z

Show changes

imported>Brinkery at 19:24, 20 November 2020

2020-11-20T19:24:20Z

Show changes

imported>Brinkery at 16:30, 16 November 2020

2020-11-16T16:30:43Z

← Older revision		Revision as of 16:30, 16 November 2020
Line 62:		Line 62:
	<br />		<br />

	28. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017.		28. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017 64: e34–e65.

	29. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017, 38(5):574-579.		29. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017, 38(5):574-579.

imported>Brinkery at 12:21, 16 November 2020

2020-11-16T12:21:58Z

imported>Brinkery at 16:11, 12 November 2020

2020-11-12T16:11:25Z

Show changes

imported>Brinkery at 15:47, 12 November 2020

2020-11-12T15:47:26Z

Show changes

imported>Brinkery at 15:26, 12 November 2020

2020-11-12T15:26:30Z

← Older revision		Revision as of 15:26, 12 November 2020
Line 59:		Line 59:

	<br />		<br />

			1. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017.

			2. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017, 38(5):574-579.

			3. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and meningitis in neurocritical care patients. <span class="ve-pasteProtect" style="mso-ansi-language:DE" data-ve-attributes="{"style":"mso-ansi-language:DE"}">J Neurol 2008, 255(11):1617-1624.</span>

			<span class="ve-pasteProtect" style="mso-ansi-language:
			DE" data-ve-attributes="{"style":"mso-ansi-language:\nDE"}">4. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter, AWMF-Registernummer: 030/089 [</span>https://www.awmf.org/leitlinien/detail/ll/030-089.html<span class="ve-pasteProtect" style="mso-ansi-language:DE" data-ve-attributes="{"style":"mso-ansi-language:DE"}">]</span>

			5. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Nau R, Blei C, Eiffert H: Intrathecal Antibacterial and Antifungal Therapies. Clin Microbiol Rev 2020, 33(3).

			6. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN: The Role of Intraventricular Antibiotics in the Treatment of Nosocomial Ventriculitis/Meningitis from Gram-Negative Pathogens: A Systematic Review and Meta-Analysis. World Neurosurg 2018, 120:e637-e650.

			7. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018, 31(1):57-68.

			8. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010, 23(4):858-883.

			9. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998, 35(3):223-246.

			10. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Mader MM, Czorlich P, Konig C, Fuhrmann V, Kluge S, Westphal M, Grensemann J: Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis. Acta Neurochir (Wien) 2018, 160(11):2099-2105.

			11. <span class="ve-pasteProtect" style="mso-tab-count:1" data-ve-attributes="{"style":"mso-tab-count:1"}"> </span>Tangden T, Enblad P, Ullberg M, Sjolin J: Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011, 52(11):1310-1316.

← Older revision		Revision as of 12:21, 16 November 2020
Line 1:		Line 1:
	'''Anmerkung der Redaktion'''		'''<big>Anmerkung der Redaktion</big>'''

			'''<big>Inhaltsverzeichnis</big>'''


Line 6:		Line 8:
	<span style="box-sizing: inherit;">2. <span style="box-sizing: inherit; font: 7pt "Times New Roman";"> </span></span> Kumta N, Roberts JA, Lipman J et al. Antibiotic distribution into cerebrospinal fluid: Can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections? Clin Pharmacokinet 2018; 57: 439–454		<span style="box-sizing: inherit;">2. <span style="box-sizing: inherit; font: 7pt "Times New Roman";"> </span></span> Kumta N, Roberts JA, Lipman J et al. Antibiotic distribution into cerebrospinal fluid: Can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections? Clin Pharmacokinet 2018; 57: 439–454

	<span style="box-sizing: inherit;">3. <span style="box-sizing: inherit; font: 7pt "Times New Roman";"> </span></span> ~~Ballmann~~ U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 2016; 20: 343		<span style="box-sizing: inherit;">3. <span style="box-sizing: inherit; font: 7pt "Times New Roman";"> </span></span> Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 2016; 20: 343

	<span style="box-sizing: inherit;">4. <span style="box-sizing: inherit; font: 7pt "Times New Roman";"> </span></span> Conen A, Fux CA, Vajkoczy P, Trampuz A. Management of infections associated with neurosurgical implanted devices. Expert Rev Anti Infect Ther 2017;15(3): 241-255		<span style="box-sizing: inherit;">4. <span style="box-sizing: inherit; font: 7pt "Times New Roman";"> </span></span> Conen A, Fux CA, Vajkoczy P, Trampuz A. Management of infections associated with neurosurgical implanted devices. Expert Rev Anti Infect Ther 2017;15(3): 241-255
Line 33:		Line 35:
	15. <span style="box-sizing: inherit;"> </span> Marais, S., et al., ''Tuberculous meningitis: a uniform case definition for use in clinical research.'' Lancet Infect Dis, 2010. '''10'''(11): p. 803-12.		15. <span style="box-sizing: inherit;"> </span> Marais, S., et al., ''Tuberculous meningitis: a uniform case definition for use in clinical research.'' Lancet Infect Dis, 2010. '''10'''(11): p. 803-12.

	16. <span style="box-sizing: inherit;"> </span> Amagon, K.I., O. ~~Awodele,~~ and A.J. Akindele, ''Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients.'' Pharmacol Res Perspect, 2017. '''5'''(5).		16. <span style="box-sizing: inherit;"> </span> Amagon K.I., Awodele O. and A.J. Akindele, ''Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients.'' Pharmacol Res Perspect, 2017. '''5'''(5).

	17. <span style="box-sizing: inherit;"> </span> Prasad, K. and M.B. ~~Singh~~, ''Corticosteroids for managing tuberculous meningitis.'' Cochrane Database Syst Rev, 2008(1): p. CD002244.		17. <span style="box-sizing: inherit;"> </span> Prasad K. and Singh M.B., ''Corticosteroids for managing tuberculous meningitis.'' Cochrane Database Syst Rev, 2008(1): p. CD002244.

	18. <span style="box-sizing: inherit;"> </span> Thwaites, G.E., et al., ''Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.'' N Engl J Med, 2004. '''351'''(17): p. 1741-51.		18. <span style="box-sizing: inherit;"> </span> Thwaites G.E., et al., ''Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.'' N Engl J Med, 2004. '''351'''(17): p. 1741-51.


	19. <span style="box-sizing: inherit;"> </span> Darlow, C.A., et al., ''Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius.'' J Infect, 2020. '''80'''(6): p. 623-629.		19. <span style="box-sizing: inherit;"> </span> Darlow C.A., et al., ''Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius.'' J Infect, 2020. '''80'''(6): p. 623-629.

	20. <span style="box-sizing: inherit;"> </span> R, N., ''S1-Leitlinie Hirnabszess~~. .~~'' In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. , 2016.		20. <span style="box-sizing: inherit;"> </span> R. N., ''S1-Leitlinie Hirnabszess'' In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie, 2016.

	21. <span style="box-sizing: inherit;"> </span> Alvis Miranda, H., et al., ''Brain abscess: Current management.'' J Neurosci Rural Pract, 2013. '''4'''(Suppl 1): p. S67-81.		21. <span style="box-sizing: inherit;"> </span> Alvis Miranda H., et al., ''Brain abscess: Current management.'' J Neurosci Rural Pract, 2013. '''4'''(Suppl 1): p. S67-81.

	22. <span style="box-sizing: inherit;"> </span> Brouwer, M.C., et al., ''Brain abscess.'' N Engl J Med, 2014. '''371'''(5): p. 447-56.		22. <span style="box-sizing: inherit;"> </span> Brouwer M.C., et al., ''Brain abscess.'' N Engl J Med, 2014. '''371'''(5): p. 447-56.

	23. <span style="box-sizing: inherit;"> </span> Mishra, A.M., et al., ''Comparison of the magnetization transfer ratio and fluid-attenuated inversion recovery imaging signal intensity in differentiation of various cystic intracranial mass lesions and its correlation with biological parameters.'' J Magn Reson Imaging, 2006. '''24'''(1): p. 52-6.		23. <span style="box-sizing: inherit;"> </span> Mishra A.M., et al., ''Comparison of the magnetization transfer ratio and fluid-attenuated inversion recovery imaging signal intensity in differentiation of various cystic intracranial mass lesions and its correlation with biological parameters.'' J Magn Reson Imaging, 2006. '''24'''(1): p. 52-6.

	24. <span style="box-sizing: inherit;"> </span> Xu, X.X., et al., ''Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis.'' Clin Radiol, 2014. '''69'''(9): p. 909-15.		24. <span style="box-sizing: inherit;"> </span> Xu X.X., et al., ''Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis.'' Clin Radiol, 2014. '''69'''(9): p. 909-15.

	25. <span style="box-sizing: inherit;"> </span> Mishra, A.K., et al., ''Molecular revolution in the diagnosis of microbial brain abscesses.'' Eur J Clin Microbiol Infect Dis, 2014. '''33'''(12): p. 2083-93.		25. <span style="box-sizing: inherit;"> </span> Mishra A.K., et al., ''Molecular revolution in the diagnosis of microbial brain abscesses.'' Eur J Clin Microbiol Infect Dis, 2014. '''33'''(12): p. 2083-93.

	26. <span style="box-sizing: inherit;"> </span> Sonneville, R., et al., ''An update on bacterial brain abscess in immunocompetent patients.'' Clin Microbiol Infect, 2017. '''23'''(9): p. 614-620.		26. <span style="box-sizing: inherit;"> </span> Sonneville R., et al., ''An update on bacterial brain abscess in immunocompetent patients.'' Clin Microbiol Infect, 2017. '''23'''(9): p. 614-620.

	27. <span style="box-sizing: inherit;"> </span> Sharma, R., K. ~~Mohandas~~, and R.P. ~~Cooke~~, ''Intracranial abscesses: changes in epidemiology and management over five decades in Merseyside.'' Infection, 2009. '''37'''(1): p. 39-43.		27. <span style="box-sizing: inherit;"> </span> Sharma R., Mohandas K., and Cooke R.P., ''Intracranial abscesses: changes in epidemiology and management over five decades in Merseyside.'' Infection, 2009. '''37'''(1): p. 39-43.

	<br />		<br />

DGI:ZNS-Infektionen/Anmerkung der Redaktion - Revision history

imported>Maximilian.schons@uk-koeln.de: Maximilian.schons@uk-koeln.de verschob die Seite DGI:ZNS Infektionen/Anmerkung der Redaktion nach DGI:ZNS-Infektionen/Anmerkung der Redaktion: Textersetzung - „ZNS Infektionen“ durch „ZNS-Infektionen“

imported>Brinkery: Der Seiteninhalt wurde durch einen anderen Text ersetzt: „== Anmerkung der Redaktion == “

imported>Brinkery at 20:08, 20 November 2020

imported>Brinkery at 20:01, 20 November 2020

imported>Brinkery at 19:24, 20 November 2020

imported>Brinkery at 16:30, 16 November 2020

imported>Brinkery at 12:21, 16 November 2020

imported>Brinkery at 16:11, 12 November 2020

imported>Brinkery at 15:47, 12 November 2020

imported>Brinkery at 15:26, 12 November 2020

imported>Brinkery: Der Seiteninhalt wurde durch einen anderen Text ersetzt: „== Anmerkung der Redaktion ==
“